Development of a countergradient parking system for gradient liquid chromatography with online biochemical detection of serine protease inhibitors.
A gradient HPLC approach in combination with a countergradient system for online biochemical detection (BCD) to screen for inhibitors of serine proteases is described. For gradient separations, this novel countergradient system was developed to produce a biocompatible constant solvent composition in the BCD. The countergradient system is based on retaining complete gradients in an additional preparative HPLC column, followed by subsequent and reversible elution to the separation column effluent. Major advantages compared with existing countergradient systems are that no additional LC pumps are needed and enhanced stability. The developed countergradient system was systematically characterized applying different gradient programs. Inhibitors eluting in a postcolumn continuous flow analysis interfere with the enzymatic release of fluorescent 7-amino-4-methylcoumarin (AMC) from an AMC-labeled peptide. The inhibitory activity of eluting substances is sensitively detected as the degree of reduced fluorescence intensity. This biochemical detection system (BCD) for proteases was validated with three known inhibitors of the benzamidine type. Their IC 50 values were in good accordance with the results of conventional plate reader assays. Finally, a small library of protease inhibitors was successfully screened with the combination of the BCD and the countergradient system.
Schebb
Nils Helge
NH
Westfalische Wilhelms-Universitat Munster, Institut fur Anorganische and Analytische Chemie, Corrensstrasse 30, 48149 Munster, Germany.
Heus
Ferry
F
Saenger
Thorsten
T
Karst
Uwe
U
Irth
Hubertus
H
Kool
Jeroen
J
D001681:Biological Assay; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D015203:Reproducibility of Results; D015842:Serine Proteinase Inhibitors / Q000032:analysis* / Q000494:pharmacology; D013917:Thrombin / Q000037:antagonists & inhibitors; D014361:Trypsin Inhibitors / Q000032:analysis / Q000494:pharmacology
D015842:Serine Proteinase Inhibitors; D014361:Trypsin Inhibitors; D013917:Thrombin